Voyager’s AADC Gene Therapy Shows Promise as Maintenance Therapy for Parkinson’s – Parkinson’s News Today
Parkinson’s News Today |
Voyager's AADC Gene Therapy Shows Promise as Maintenance Therapy for Parkinson's
Parkinson’s News Today The company presented ongoing Phase 1b trial (NCT01973543) results at the Oct. 17-20 Congress of the European Society of Gene and Cell Therapy (ESGCT) in Berlin, in a talk titled “Intraputaminal AADC gene therapy for advanced Parkinson's disease: … |
